Abstract
The middle ear muscle reflex (MEMR) and medial olivocochlear reflex (MOCR) are increasingly studied for their role in suprathreshold auditory processing. However, recording these reflexes in humans is potentially complicated by age-related (sub)clinical hearing loss and co-activation. This study investigates the influence of age-related sensorineural and audiometric hearing loss, and how MEMR activation contaminates MOCR recordings.
Three test groups were included: young normal-hearing adults, middle-aged normal- hearing adults, and middle-aged adults with hearing loss. The sensorineural auditory status was assessed using distortion-product otoacoustic emissions (DPOAEs) and envelope following responses. MEMR recordings were evaluated using wideband stimuli and MOCR was recorded at elicitor levels of 60 and 75 dB to evaluate MEMR co-activation.
MEMR amplitude, but not threshold, was related to age; however, this effect was significantly reduced after correcting for DPOAE and extended high-frequency thresholds. Associations between MOCR strength and age or hearing-related measures were mixed and reliable recordings were challenging in participants with hearing loss due to poor OAE baselines. MEMR co-activation was detectable in the click response and could alter MOCR-induced suppression.
These findings suggest that MEMR amplitude may be a marker of subclinical cochlear damage, while MOCR sensitivity to hearing status appears more closely tied to audiometric than subclinical sensorineural status. Clinical measurements can be improved using broadband stimuli, accounting for cochlear damage, and defining criteria for reflex co-activation.
Competing Interest Statement
The authors have declared no competing interest.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Ethics Committee of Ghent University (Ethics Code: ONZ-2022-0352 E01) on September 08, 2022.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
We simplified many parts of the paper, particularly with regard to minor adjustments to the focus of the paper and a subsequent change in the statistical approach, which now focuses on group comparisons rather than regression analyses.
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Funder Information Declared
